Matches in Wikidata for { <http://www.wikidata.org/entity/Q80017670> ?p ?o ?g. }
Showing items 1 to 53 of
53
with 100 items per page.
- Q80017670 description "article scientifique publié en 2007" @default.
- Q80017670 description "artículu científicu espublizáu en marzu de 2007" @default.
- Q80017670 description "im März 2007 veröffentlichter wissenschaftlicher Artikel" @default.
- Q80017670 description "scientific article published on 26 March 2007" @default.
- Q80017670 description "wetenschappelijk artikel" @default.
- Q80017670 description "наукова стаття, опублікована в березні 2007" @default.
- Q80017670 name "Mature results of the Ottawa phase II study of intermittent androgen-suppression therapy in prostate cancer: clinical predictors of outcome" @default.
- Q80017670 name "Mature results of the Ottawa phase II study of intermittent androgen-suppression therapy in prostate cancer: clinical predictors of outcome" @default.
- Q80017670 type Item @default.
- Q80017670 label "Mature results of the Ottawa phase II study of intermittent androgen-suppression therapy in prostate cancer: clinical predictors of outcome" @default.
- Q80017670 label "Mature results of the Ottawa phase II study of intermittent androgen-suppression therapy in prostate cancer: clinical predictors of outcome" @default.
- Q80017670 prefLabel "Mature results of the Ottawa phase II study of intermittent androgen-suppression therapy in prostate cancer: clinical predictors of outcome" @default.
- Q80017670 prefLabel "Mature results of the Ottawa phase II study of intermittent androgen-suppression therapy in prostate cancer: clinical predictors of outcome" @default.
- Q80017670 P1433 Q80017670-83D6809E-6BA1-4F25-AAE3-43BDFDF64660 @default.
- Q80017670 P1476 Q80017670-B61125D0-633D-482D-B457-7B934DE8A61A @default.
- Q80017670 P2093 Q80017670-117DF18C-8502-44B8-8D52-DC7D78702A0A @default.
- Q80017670 P2093 Q80017670-2458AB53-07A0-412E-BD7C-49B135B64474 @default.
- Q80017670 P2093 Q80017670-40355CC9-C777-4A1F-8B1C-34DD2D4BFFB2 @default.
- Q80017670 P2093 Q80017670-5C9B8E2A-5E92-47DF-8524-6C1496A7D5B1 @default.
- Q80017670 P2093 Q80017670-70B49114-9B44-4A59-A8B3-A41549636FA5 @default.
- Q80017670 P2093 Q80017670-BAE10B84-DB05-46B4-B29E-02467C39F2D5 @default.
- Q80017670 P2093 Q80017670-FB47E82E-25B5-4B25-B39A-CEC7A0C02236 @default.
- Q80017670 P2093 Q80017670-FBA34A20-47EE-4CD1-B0B0-6E37087C5EBE @default.
- Q80017670 P304 Q80017670-1B950C27-E883-4AC3-9FE1-8843B7F03CA9 @default.
- Q80017670 P31 Q80017670-152FE092-EFF0-4770-9940-E2A56CA7A07B @default.
- Q80017670 P356 Q80017670-51EE6D5E-12F2-438B-A3F8-0FE5E8A3078C @default.
- Q80017670 P407 Q80017670-017E2C30-55AB-43B9-B92B-C7EC3BA04FE5 @default.
- Q80017670 P433 Q80017670-3DEB0167-A607-4ED8-8E66-22FA0C97F917 @default.
- Q80017670 P478 Q80017670-7F7A72AD-94EB-46CE-8E8D-189B542E1210 @default.
- Q80017670 P577 Q80017670-3765C9B7-F6A3-4D28-92EA-9AE9F6EA8D27 @default.
- Q80017670 P698 Q80017670-3BF5CE0B-B5D3-43A5-89E4-71AE1F2EF0F5 @default.
- Q80017670 P921 Q80017670-469669BB-22A7-462E-AEDC-BAEA3B1513E9 @default.
- Q80017670 P356 J.IJROBP.2006.12.072 @default.
- Q80017670 P698 17379438 @default.
- Q80017670 P1433 Q2296252 @default.
- Q80017670 P1476 "Mature results of the Ottawa phase II study of intermittent androgen-suppression therapy in prostate cancer: clinical predictors of outcome" @default.
- Q80017670 P2093 "Gad Perry" @default.
- Q80017670 P2093 "Johanna N Spaans" @default.
- Q80017670 P2093 "Juanita Crook" @default.
- Q80017670 P2093 "Libni Eapen" @default.
- Q80017670 P2093 "Roanne Segal" @default.
- Q80017670 P2093 "Shawn Malone" @default.
- Q80017670 P2093 "Simone Dahrouge" @default.
- Q80017670 P2093 "Victor Gallant" @default.
- Q80017670 P304 "699-706" @default.
- Q80017670 P31 Q13442814 @default.
- Q80017670 P356 "10.1016/J.IJROBP.2006.12.072" @default.
- Q80017670 P407 Q1860 @default.
- Q80017670 P433 "3" @default.
- Q80017670 P478 "68" @default.
- Q80017670 P577 "2007-03-26T00:00:00Z" @default.
- Q80017670 P698 "17379438" @default.
- Q80017670 P921 Q181257 @default.